Hutchison MediPharma Limited Enters into Drug Discovery and Development Partnership With Ortho-McNeil-Janssen Pharmaceuticals, Inc. // Chi-Med
AIM: £45.10 (+0.35) | Nasdaq: $28.50 (-1.21)
News Archive
Previous Article   |   Next Article
Innovation Platform, RNS Announcements | 23 Dec 2008

Hutchison MediPharma Limited Enters into Drug Discovery and Development Partnership With Ortho-McNeil-Janssen Pharmaceuticals, Inc.

1 Item
a081223